Dr. Bertoch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
650 E 4500 S
Suite 100
Salt Lake City, UT 84107Phone+1 928-830-7354
Summary
- Dr. Todd Bertoch, M.D. is a diplomat of the American Board of Anesthesiology. He graduated Summa Cum Laude with a Bachelor of Science Degree in Biochemistry from California State University at Fullerton and received a Doctor of Medicine degree from the Uniformed Services University of the Health Sciences in Bethesda, Maryland. After an internship in Internal Medicine, he completed his Anesthesiology residency at Wilford Hall Medical Center in San Antonio, Texas, where he was Chief Resident and received the Arthur B. Tarrow Outstanding Resident Award. He is a member of the esteemed Alpha Omega Alpha Honor Medical Society.
Dr. Bertoch served as an anesthesiologist in the United States Air Force until 2006. Following the terrorist attacks of September 11, 2001, Dr. Bertoch participated in combat deployments to Mindanao in the southern Philippines and later to Balad Air Base in Iraq in support of Operation Enduring Freedom. He is a recipient of the Air Force Achievement Medal, the Air Force Commendation Medal, and the Meritorious Service Medal.
After completing his military service, Dr. Bertoch served for 11 years as the managing partner of Prescott Anesthesia in Prescott, Arizona where his practice included a focus on cardiovascular surgery, chronic pain management and addiction medicine. Since joining CenExel JBR Clinical research in 2017, he has served as Principal Investigator for over 70 clinical trials, defended development programs for sponsors before the FDA, been invited to present study results on behalf of clients at professional meetings, designed and authored numerous clinical trial protocols, and has helped author several industry-related articles and white papers.
Education & Training
- San Antonio Uniformed Services Health Education ConsortiumResidency, Anesthesiology, 1996 - 1999
- San Antonio Uniformed Services Health Education ConsortiumInternship, Internal Medicine, 1995 - 1996
- UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 2002 - Present
- UT State Medical License 2016 - 2026
- AZ State Medical License 2006 - 2022
- PA State Medical License 1998 - 2002
- American Board of Anesthesiology Anesthesiology
Clinical Trials
- Efficacy and Safety Study of a Test Naproxen Sodium 220mg Tablet in Postoperative Dental Pain Start of enrollment: 2018 Aug 13
- Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management Start of enrollment: 2018 Jul 31
- Efficacy of 300 mg Ibuprofen Prolonged-Release Tablets for the Treatment of Pain After Surgical Removal of Impacted Third Molars Start of enrollment: 2019 Apr 29
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsComparison of the Efficacy of HSK3486 and Propofol for Induction of General Anesthesia in Adults: A Multicenter, Randomized, Double-blind, Controlled, Phase 3 Noninfer...Tong J Gan, Todd Bertoch, Ashraf S Habib, Pangke Yan, Rong Zhou
Anesthesiology. 2024-04-01 - 4 citationsAnalgesic efficacy of naproxen sodium versus hydrocodone/acetaminophen in acute postsurgical dental pain: a randomized, double-blind, placebo-controlled trial.Stephen A Cooper, Paul J Desjardins, Todd Bertoch, Alberto Paredes-Diaz, Emanuel Troullos
Postgraduate Medicine. 2022-06-01 - 13 citationsOpioid-free recovery after herniorrhaphy with HTX-011 as the foundation of a multimodal analgesic regimen.Neil Singla, Peter Winkle, Todd Bertoch, Jia Hu, Alina Beaton
Surgery. 2020-09-14
Press Mentions
- Cali Biosciences Announces Successful Results in Phase IIb Study of Long-Acting Ropivacaine (CPL-01) for Non-Opioid Treatment of Post-Operative PainMarch 22nd, 2022
- Cali Biosciences Initiates Phase 2b Study of Long-Acting Ropivacaine for Non-Opioid Treatment of Post-Operative PainAugust 12th, 2021
- JBR Clinical Research Surgical Center Earns Prestigious AAAASF AccreditationJuly 9th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: